Lexicon Pharmaceuticals (LXRX) Debt Ratio (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has reported Debt Ratio for 17 consecutive years, with 0.18 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt Ratio fell 45.37% year-over-year to 0.18; the TTM figure through Mar 2026 stood at 0.18 (down 45.37% YoY), while the FY2025 annual figure was 0.29, down 13.14% from the prior year.
• Debt Ratio retreated to 0.18 in Q1 2026 per LXRX's latest filing, from 0.29 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.43 in Q4 2023 and bottomed at 0.12 in Q3 2022.
• Historically, Debt Ratio has averaged 0.27 across 5 years, with a median of 0.27 in 2025.
• Annual changes were most pronounced in 2022 — Debt Ratio soared 208.94% — and 2026, when it sank 45.37%.
• Lexicon Pharmaceuticals' Debt Ratio stood at 0.25 in 2022, then jumped by 73.47% to 0.43 in 2023, then dropped by 22.51% to 0.34 in 2024, then dropped by 13.14% to 0.29 in 2025, then plunged by 36.69% to 0.18 in 2026.
• Business Quant data shows LXRX's Debt Ratio at 0.18 in Q1 2026, 0.29 in Q4 2025, and 0.27 in Q3 2025.